Skip to main content

Table 1 Clinical features of AIS and LPA in the cohort1 and 2

From: Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma

Factors

c1

c2

 

AIS

LPA

AIS

LPA

Sex

    

 Male

7

2

5

13

 Female

3

8

11

12

Age

    

 ≤60

3

3

7

4

 >60

7

7

9

21

Smoking

    

 No

9

8

16

12

 Yes

1

2

0

13

Location

    

 Peripheral

10

8

16

19

 Central

0

2

0

6

Surgical procedure

    

 Lobectomy

10

10

16

24

 Pneumonectomy

0

0

0

1

laterality

    

 Left

5

4

10

9

 Right

5

6

6

16

p N status

    

 N0

10

10

16

16

 N1

0

0

0

6

 N2

0

0

0

3

pT status

    

 T1

10

8

16

15

 T2-3

0

2

0

10

  1. c1: Clinical-pathological characteristics of the 10 patients with AIS and LPA used for cDNA microarray analysis.
  2. c2: Clinical-pathological characteristics of the 41 patients in the validation cohort.